Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 26


Association between hepatitis B vaccine antibody response and CD4 reconstitution after initiation of combination antiretroviral therapy in HIV-infected persons.

Allen K, Mesner O, Ganesan A, O'Bryan TA, Deiss RG, Agan BK, Okulicz JF.

BMC Infect Dis. 2015 May 1;15:203. doi: 10.1186/s12879-015-0937-5.


Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.

Okulicz JF, Le TD, Agan BK, Camargo JF, Landrum ML, Wright E, Dolan MJ, Ganesan A, Ferguson TM, Smith DM, Richman DD, Little SJ, Clark RA, He W, Ahuja SK.

JAMA Intern Med. 2015 Jan;175(1):88-99. doi: 10.1001/jamainternmed.2014.4010.


Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil.

Cardoso SW, Luz PM, Velasque L, Torres T, Coelho L, Freedberg KA, Veloso VG, Walensky RP, Grinsztejn B.

AIDS Res Ther. 2014 Sep 1;11:29. doi: 10.1186/1742-6405-11-29. eCollection 2014.


Hepatitis B vaccine responsiveness and clinical outcomes in HIV controllers.

Okulicz JF, Mesner O, Ganesan A, O'Bryan TA, Deiss RG, Agan BK.

PLoS One. 2014 Aug 21;9(8):e105591. doi: 10.1371/journal.pone.0105591. eCollection 2014.


Recent trends in early stage response to combination antiretroviral therapy in Australia.

McManus H, Hoy JF, Woolley I, Boyd MA, Kelly MD, Mulhall B, Roth NJ, Petoumenos K, Law MG; Australian HIV Observational Database.

Antivir Ther. 2015;20(2):131-9. doi: 10.3851/IMP2774. Epub 2014 Apr 4.


HIV outcomes in Hepatitis B virus coinfected individuals on HAART.

Chun HM, Mesner O, Thio CL, Bebu I, Macalino G, Agan BK, Bradley WP, Malia J, Peel SA, Jagodzinski LL, Weintrob AC, Ganesan A, Bavaro M, Maguire JD, Landrum ML; Infectious Disease Clinical Research Program HIV Working Group.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):197-205. doi: 10.1097/QAI.0000000000000142.


Delayed-type hypersensitivity (DTH) test anergy does not impact CD4 reconstitution or normalization of DTH responses during antiretroviral therapy.

Minidis NM, Mesner O, Agan BK, Okulicz JF.

J Int AIDS Soc. 2014 Feb 4;17:18799. doi: 10.7448/IAS.17.1.18799. eCollection 2014.


Combining epidemiologic and biostatistical tools to enhance variable selection in HIV cohort analyses.

Rentsch C, Bebu I, Guest JL, Rimland D, Agan BK, Marconi V.

PLoS One. 2014 Jan 29;9(1):e87352. doi: 10.1371/journal.pone.0087352. eCollection 2014.


Race/ethnicity and HAART initiation in a military HIV infected cohort.

Johnson EN, Roediger MP, Landrum ML, Crum-Cianflone NF, Weintrob AC, Ganesan A, Okulicz JF, Macalino GE, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

AIDS Res Ther. 2014 Jan 24;11(1):10. doi: 10.1186/1742-6405-11-10.


The VACS index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy.

Bebu I, Tate J, Rimland D, Mesner O, Macalino GE, Ganesan A, Okulicz JF, Bavaro M, Weintrob AC, Justice AC, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):226-30. doi: 10.1097/QAI.0000000000000045.


Virologic and immunologic outcome of HAART in Human Immunodeficiency Virus (HIV)-1 infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, Ethiopia.

Kassa D, Gebremichael G, Alemayehu Y, Wolday D, Messele T, van Baarle D.

AIDS Res Ther. 2013 Jul 10;10:18. doi: 10.1186/1742-6405-10-18. eCollection 2013.


A comparison of HAART outcomes between the US military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS).

Guest JL, Weintrob AC, Rimland D, Rentsch C, Bradley WP, Agan BK, Marconi VC; I D C R P H I V Working Group.

PLoS One. 2013 May 1;8(5):e62273. doi: 10.1371/journal.pone.0062273. Print 2013.


Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort.

Moore DJ, Roediger MJ, Eberly LE, Blackstone K, Hale B, Weintrob A, Ganesan A, Agan BK, Letendre SL, Crum-Cianflone NF.

PLoS One. 2012;7(11):e47310. doi: 10.1371/journal.pone.0047310. Epub 2012 Nov 8.


The impact of enzyme-inducing antiepileptic drugs on antiretroviral drug levels: a case-control study.

Okulicz JF, Grandits GA, French JA, Perucca E, George JM, Landrum ML, Acosta EP, Birbeck GL.

Epilepsy Res. 2013 Feb;103(2-3):245-53. doi: 10.1016/j.eplepsyres.2012.07.009. Epub 2012 Jul 24.


Results of a 25-year longitudinal analysis of the serologic incidence of syphilis in a cohort of HIV-infected patients with unrestricted access to care.

Ganesan A, Fieberg A, Agan BK, Lalani T, Landrum ML, Wortmann G, Crum-Cianflone NF, Lifson AR, Macalino G; Infectious Disease Clinical Research Program HIV Working Group.

Sex Transm Dis. 2012 Jun;39(6):440-8. doi: 10.1097/OLQ.0b013e318249d90f.


Spontaneous virologic suppression in HIV controllers is independent of delayed-type hypersensitivity test responsiveness.

Okulicz JF, Grandits GA, Dolan MJ, Marconi VC, Wortmann G, Landrum ML.

AIDS Res Ther. 2012 Apr 2;9:10. doi: 10.1186/1742-6405-9-10.


Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.

Landrum ML, Hullsiek KH, O'Connell RJ, Chun HM, Ganesan A, Okulicz JF, Lalani T, Weintrob AC, Crum-Cianflone NF, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

PLoS One. 2012;7(3):e33488. doi: 10.1371/journal.pone.0033488. Epub 2012 Mar 22.


Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort.

Lifson AR, Krantz EM, Grambsch PL, Macalino GE, Crum-Cianflone NF, Ganesan A, Okulicz JF, Eaton A, Powers JH, Eberly LE, Agan BK; Infectious Disease Clinical Research Program HIV/STI Working Group.

AIDS Res Ther. 2012 Feb 10;9(1):4. doi: 10.1186/1742-6405-9-4.


Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?

Johnstone-Robertson SP, Hargrove J, Williams BG.

HIV AIDS (Auckl). 2011;3:9-17. doi: 10.2147/HIV.S7278. Epub 2011 Feb 1.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk